Recent study findings have suggested that the rapidly expanding family of GLP-1 medications, which includes Ozempic and Wegovy, is also demonstrating early promise in treating brain-related ailments such as mental health issues, Alzheimer’s disease, and even Parkinson’s disease after being successful in treating diabetes and obesity.
In a trial, Lixisenatide was found to lessen the progression of tremors and slow movement, hailed as a “significant step forward” for treating the disease.
Ozempic-like Injections Could Prevent Parkinson’s Disease
Under the brand name Lyxumia, scientists think it might protect the brain and lessen the harm caused by the disease.
Around 156 participants who had recently received a Parkinson’s diagnosis participated in the study.
While the other half received a placebo in addition to their regular medicine, the other half received daily injections of the approved diabetes treatment.
After a full year, the motor symptoms of those on lixisenatide medication slowed down and even showed some indications of improvement, whereas the other group’s problems …